CN Stock MarketDetailed Quotes
688626 Xiangyu Medical
- 31.79
- -2.12-6.25%
Market Closed Dec 23 15:00 CST
5.09BMarket Cap41.88P/E (TTM)
33.89High31.70Low18.85KlotVolume33.68Open33.91Pre Close61.29MTurnover1.18%Turnover Ratio22.39P/E (Static)160.00MShares53.4852wk High2.51P/B5.09BFloat Cap21.5852wk Low40.69Limit Up160.00MShs Float123.74Historical High27.13Limit Down6.46%Amplitude21.58Historical Low0.53Dividend TTM32.51Avg Price12.48KlotAsk1.67%Div YieldTTM100Lot Size5.61KlotBid
Xiangyu Medical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 5.09%576.1M | -0.95%372.92M | -3.41%157.39M | 20.33%786.02M | 23.93%548.18M | 41.88%376.49M | 72.65%162.96M | 13.98%653.19M | 19.90%442.32M | 24.49%265.36M |
| Refunds of taxes and levies | -14.41%12.54M | -2.25%8.69M | 23.38%4.65M | 60.66%17.11M | 135.01%14.65M | 155.33%8.89M | 150.88%3.77M | 60.96%10.65M | 64.11%6.23M | 39.91%3.48M |
| Cash received relating to other operating activities | -42.73%48.62M | -50.77%20.19M | -21.76%13.01M | 19.14%98.18M | 18.27%84.89M | 57.86%41.01M | 61.26%16.63M | -3.86%82.41M | -5.01%71.78M | -53.93%25.98M |
| Cash inflows from operating activities | -1.62%637.26M | -5.77%401.8M | -4.53%175.05M | 20.78%901.31M | 24.48%647.72M | 44.63%426.39M | 72.65%183.35M | 12.15%746.25M | 16.08%520.33M | 8.38%294.82M |
| Goods services cash paid | -0.40%199.28M | 14.18%149.74M | -25.99%40.11M | 28.51%257.21M | 23.04%200.09M | 22.77%131.14M | 21.73%54.19M | 10.90%200.16M | 14.72%162.62M | 40.05%106.82M |
| Staff behalf paid | 20.20%172.92M | 13.89%115.01M | 0.69%52.41M | 10.68%212.48M | 3.06%143.86M | 5.03%100.98M | 12.08%52.05M | 24.26%191.98M | 25.83%139.59M | 34.64%96.14M |
| All taxes paid | 1.04%49.28M | 0.63%34.94M | -4.89%20.95M | 38.91%75.53M | 6.91%48.77M | 38.63%34.72M | 39.63%22.03M | -20.99%54.37M | -21.43%45.62M | -43.58%25.05M |
| Cash paid relating to other operating activities | 43.18%122.79M | 17.88%69.54M | 137.74%44.29M | 13.39%128.18M | 3.17%85.76M | 21.55%58.99M | -20.62%18.63M | 18.10%113.04M | 25.90%83.13M | 11.09%48.53M |
| Cash outflows from operating activities | 13.75%544.28M | 13.32%369.24M | 7.39%157.76M | 20.35%673.4M | 11.03%478.49M | 17.83%325.84M | 12.82%146.9M | 12.02%559.55M | 14.38%430.95M | 17.30%276.54M |
| Net cash flows from operating activities | -45.06%92.98M | -67.62%32.56M | -52.55%17.3M | 22.07%227.91M | 89.35%169.24M | 450.10%100.55M | 251.84%36.45M | 12.55%186.7M | 25.03%89.38M | -49.61%18.28M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | --24.72K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received from returns on investments | -57.70%3.2M | -54.50%3.19M | -60.88%1.08M | -35.84%11.98M | -48.01%7.56M | -39.27%7M | -46.20%2.77M | 106.87%18.68M | 646.89%14.53M | 3,624.61%11.53M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --13K | --13K | ---- | 30.02%87.44K | ---- | ---- | ---- | 66.47%67.26K | ---- | ---- |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | --225.15K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | -78.72%321.05M | -67.88%321M | -85.02%54M | -30.99%1.76B | -16.83%1.51B | -29.15%999.5M | -39.04%360.5M | 149.11%2.55B | --1.81B | --1.41B |
| Cash inflows from investing activities | -78.61%324.26M | -67.79%324.2M | -84.84%55.08M | -31.01%1.77B | -17.08%1.52B | -29.23%1.01B | -39.10%363.27M | 148.74%2.57B | 93,835.94%1.83B | 459,285.12%1.42B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -8.53%352.19M | 6.94%244.63M | 32.75%125.91M | 136.00%479.26M | 219.95%385.03M | 208.78%228.75M | 201.32%94.85M | 51.65%203.07M | 156.07%120.34M | 307.54%74.08M |
| Cash paid to acquire investments | ---- | ---- | ---- | 208.39%10.1M | --10M | ---- | ---- | -76.60%3.28M | ---- | ---- |
| Cash paid relating to other investing activities | -88.36%159.05M | -82.53%159M | -75.52%59M | -40.30%1.52B | -23.15%1.37B | -30.85%910M | -61.00%241M | 52.42%2.54B | 166.27%1.78B | 101.50%1.32B |
| Cash outflows from investing activities | -70.97%511.24M | -64.56%403.63M | -44.94%184.91M | -26.97%2.01B | -7.21%1.76B | -18.08%1.14B | -48.29%335.85M | 51.37%2.75B | 158.06%1.9B | 107.08%1.39B |
| Net cash flows from investing activities | 23.67%-186.98M | 39.94%-79.43M | -573.43%-129.82M | -31.10%-234.54M | -251.95%-244.97M | -511.36%-132.25M | 151.79%27.42M | 77.12%-178.9M | 90.51%-69.6M | 104.79%32.15M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.63%3.98M | -99.63%3.98M | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.98M | ---- | ---- |
| Cash from borrowing | 332.00%324M | 109.33%157M | 185.45%157M | 63.04%75M | 74.42%75M | 74.42%75M | 44.74%55M | --46M | --43M | --43M |
| Cash received relating to other financing activities | -17.54%168M | -15.85%110M | --110M | -50.53%7M | --203.73M | --130.73M | ---- | --14.15M | ---- | ---- |
| Cash inflows from financing activities | 76.51%492M | 29.78%267M | 385.45%267M | 27.85%82M | 493.24%278.73M | 378.43%205.73M | 44.74%55M | -94.09%64.14M | -95.62%46.98M | -96.02%43M |
| Borrowing repayment | 230.95%182.03M | 27.29%70.01M | ---- | 67.79%72.15M | 44.74%55M | 44.74%55M | ---- | -14.00%43M | -24.00%38M | -24.00%38M |
| Dividend interest payment | 116.74%85.18M | 119.27%84.42M | -92.39%21.25K | -32.71%40.46M | -34.56%39.3M | -35.84%38.5M | 414.99%279.3K | 1.20%60.13M | 1.08%60.05M | 1.01%60.01M |
| Cash payments relating to other financing activities | 109.69%73.56M | 348.98%68.89M | 1,840.43%61.84M | -64.26%27.89M | -52.12%35.08M | -79.06%15.34M | --3.19M | 268.69%78.05M | 247.55%73.27M | 247.55%73.27M |
| Cash outflows from financing activities | 163.38%340.77M | 105.18%223.32M | 1,684.68%61.86M | -22.45%140.5M | -24.48%129.38M | -36.45%108.84M | -90.89%3.47M | 38.75%181.18M | 31.29%171.32M | 31.26%171.28M |
| Net cash flows from financing activities | 1.26%151.23M | -54.92%43.68M | 298.07%205.14M | 50.02%-58.5M | 220.12%149.35M | 175.52%96.88M | 95,120.46%51.53M | -112.25%-117.04M | -113.18%-124.34M | -113.52%-128.28M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 245.57%125.09K | 96.07%-3.91K | 89.24%-7.05K | 23.67%-16.49K | -138.05%-85.93K | -76.18%-99.49K | -135.74%-65.57K | 0.20%-21.61K | 1,086.92%225.81K | -299.95%-56.47K |
| Net increase in cash and cash equivalents | -21.99%57.36M | -104.90%-3.19M | -19.71%92.6M | 40.37%-65.15M | 170.47%73.53M | 183.54%65.09M | 249.72%115.34M | -132.24%-109.27M | -137.12%-104.34M | -124.80%-77.91M |
| Add:Begin period cash and cash equivalents | -9.09%651.77M | -9.09%651.77M | -9.09%651.77M | -13.23%716.92M | -13.23%716.92M | -13.23%716.92M | -13.23%716.92M | 69.56%826.19M | 69.58%826.28M | 69.56%826.19M |
| End period cash equivalent | -10.29%709.13M | -17.06%648.58M | -10.56%744.37M | -9.09%651.77M | 9.49%790.45M | 4.51%782.01M | 11.09%832.26M | -13.23%716.92M | -6.04%721.94M | -6.63%748.28M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
